Skip to content
healthcare.dev

OPDIVO QVANTIG

NDC 0003-3120, nivolumab and hyaluronidase-nvhy, injection, solution, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-3120
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761381
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NIVOLUMAB120 mg/mL
  • HYALURONIDASE (HUMAN RECOMBINANT)2000 U/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
0003-3120-01000033120011 VIAL, SINGLE-DOSE in 1 CARTON (0003-3120-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f8c38fa-42f4-4387-9e8c-7a1c66855d8b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-3120

Use it

Look up 0003-3120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-3120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.